2026-04-30T02:24:56Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/2455-5363.000038 2020-12-22 PTZ.GJIDCR:VOL6

A strategy for finding new medicines against the novel coronavirus disease (COVID-19) derived from base pairing with DNA damages Katsuhito Kino Takayuki Ohshima Taishu Kawada Takanobu KobayashiHiroshi Miyazawa<p>The spread of the novel coronavirus disease (COVID-19) has caused a global pandemic. Exiting agents that act on proteins including 3-chymotrypsin-like protease (3CLpro), papain-like protease (PLpro), helicase, RNA-dependent RNA polymerase (RdRp), spike glycoprotein (S protein), and others in similar viruses [1,2] are likely used as antiviral drugs against the novel coronavirus (SARS-CoV-2). Data on Chemical Abstract Service show that the potential drug candidates against 3CLpro and RdRp are more than those against other targets [2].</p><p><br></p> Global Journal of Infectious Diseases and Clinical Research - Peertechz Publications 2020-12-22 Opinion https://doi.org/10.17352/2455-5363.000038 en Copyright © Katsuhito Kino et al.